Member Info for Midas3316

Haven’t seen any figures for Leap since it really took off. The only figures I’ve seen is older ones before they made it big.

For the 12 months ended 31 December 2015, Leap Gaming had revenue of US$247,000 and incurred a trading loss of
US$640,000

For the 12 months ended 31 December 2017, Leap Gaming incurred a trading loss of US$ 973,000 on turnover of US$537,548

Leap Gaming reported impressive year-on-year ("y-o-y") improvements in performance, including a 70% y-o-y increase in gross gaming revenues (August 2019 compared to August 2018)

It wasn’t a surprise to have the new directors appointed as it was mentioned months previously.

Following the General Meeting, Motif Bio will accelerate the wind down or disposal of Motif Inc. This will involve the sale, wind-down or divestment of all or substantially all of the Company's existing business, assets and investments. This represents a fundamental change of business and upon an independent director and officer being appointed for the completion of the wind-down or disposal of Motif Inc., the Company will be classified as an AIM Rule 15 cash shell. A further announcement confirming the appointment of an independent director and officer to implement the completion of the wind-down or disposal or Motif Inc. will be made in due course.

When Motif was around the £250k - £500k MCAP - 0.04 to 0.08 range just a few weeks back there was still nobody interested. At that price it was cheap for a shell company. Now it’s 10 times that.

Yes it has been rejected twice Mark.

This is not the first time that Iclaprim has been rejected by the FDA.
In 2009, when Iclaprim was proposed for the treatment of complicated skin and skin structure infections (cSSSI), the FDA indicated that additional clinical data are required to demonstrate efficacy, and refused to approve it. Iclaprim was under the aegis of Arpida, a Swiss company, then. Motif Bio acquired the rights to Iclaprim from Arpida in 2015.

If you research Iclaprim you will see it’s been passed around by several companies. Roche one of the biggest companies in the field had discovered it first over twenty years back. Since been passed around to several companies and had just as many stage 3 trials. Its been rejected by the FDA twice. and even when motif was down to a MCAP of just £250k as recent as a couple of months back nobody wanted to buy in. There has been recent interest with the new board appointments ( which was already expected and announced months earlier - as part of the wind down process having independent directors appointed ) Maybe something is going on in the background ???? Who knows. Why else would it have such a high MCAP now when all it has is a listing. Maybe riddler knows why!!! Oh wait he’s onto his next pump and dump.

Can’t believe people still believe the likes of riddler who is well known to ramp the living daylights out of a share as he is busy selling He’s been doing this for years on twitter. A week or so on each share then onto the next one. Of course if anyone tries to call him out you would be the ‘deramper’.

14 months ago it was over 40p.

Pmsl. Novice.

A share that is still overpriced. Probably dropping back to a more reasonable level. Did you post my TEK post to buy at 3.75p. Then to sell 2 weeks later at 20p. You maybe missed those

???? What part did I get wrong

Not learning much from this lot . Too many of the twitter ramp crew around

I’m here watching you all.

Sounds like you’re talking in “riddles” Bobby. Enjoy what’s left of the weekend. Back to 9 - 5 again tomorrow.

Yes. Monday has an RNS logged. I can only guess what it is.

The worst probably being the well known pump and dump artist on twitter. It’s disgusting that they mislead people into buying as they are selling and moving onto the next scam. Watch out. Batman will be after you x

Not sure about the Jag ...Mazik. This is probably more realistic. https://www.ebay.co.uk/itm/Islabike-Beinn-20-Large-6-Teal-Blue-Excellent-Condition-Ready-to-go/324160953195?hash=item4b797f9b6b:g:WyIAAOSwwlxetpr9

Are you Mark also ??,

Mark Iclaprim is owned by Motif inc. Which is owned by Hercules. Motif plc is what you have shares in. They don’t have anything except a bit cash.

Munch. I don’t know how to make it much clearer. Yes probably a RTO. BUT Motif plc. Which is what you have shares in DONT. DO NOT. HAVE NOT. GOT Iclaprim anymore.

Munch. That would be great news for a new treatment. But Motif can only benefit from a RTO. If at all. Motif have no interest in Iclaprim

That would be good news for Iclaprim and Motif inc. what about Motif plc